International Survey on lymph node management in node positive breast cancer patients after neoadjuvant chemotherapy
Topic:International discrepancies on the axillary management amongradiation oncologists and breast surgeons
PI: Maria Luisa Gasparri
Core team: M.L. Gasparri, J. de Boniface, P. Poortmans, T. Kühn, O.D. Gentilini, O. Kaidar-Person
Supporting societies:
- European Breast Cancer Research Association of Surgical Trialists (Eubreast)
- American Society of Breast Surgeons
- Arbeitsgemeinschaft für gynäkologische Onkologie
- Associazione Nazionale Italiana Senologi Chirurghi
- Collegio Italiano dei Senologi
- Deutsche Gesellschaft für Radioonkologie
- Deutsche Gesellschaft für Senologie
- Global Breast Hub
- Israel Breast Surgeons Society
- Israel Radiation Therapy society
- Swiss Society of Senology
- Scuola Italiana di Senologia
- Società Polispecialistica Italiana Giovani Chirurghi
- Swedish Breast Cancer Group
- The Oncoplastic Breast Consortium
Study design: international web-survey
Brief presentation: There is no consensus on the axillary management following primary systemic treatment in clinically node-positive breast cancer patients. The discrepancies in the breast surgical and radiation therapy approaches have been «quantified» testing a representative sample of 349 breast surgeons and radiation oncologists from 45 countries. The resulted heterogeneity among countries and centres, reinforces the rationale of the ongoing AXSANA (EUBREAST-3) study.
Publications: Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey
